Brokerages Set Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Price Target at $28.00 : vimarsana.com

Shares of Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Free Report) have been given an average recommendation of “Hold” by the three research firms that are covering the company, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold recommendation. The average twelve-month target price among brokers that have issued ratings on the […]

Related Keywords

Hong Kong , United States , , Tower Research Capital , Envestnet Asset Management Inc , Hong Kong Ltd , Nasdaq , Atara Biotherapeutics Company Profile , Atara Biotherapeutics Inc , Get Free Report , Marketbeat Ratings , Kong Ltd , Research Capital , Sigma Investments , Asset Management , Quantbot Technologies , Get Free , Atara Biotherapeutics , Nasdaq Atra , Atra , Medical , Ratings , Consensus ,